Evidence map›Paper›PMID 36684093›Full record

ArticleBioengineering & translational medicine2023

Cold air plasma improving rheumatoid arthritis via mitochondrial apoptosis pathway.

Chengbiao Ding, Leying Ni, Qi Liu, Chenxu Zhou, Guomin Wang, Paul K Chu, Zhengwei Wu

Open access · goldAbstract read
In one paragraph

Article in Bioengineering & translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Chengbiao DingSchool of Nuclear Science and Technology University of Science and Technology of China Hefei China.
Leying NiDepartment of Rehabilitation Medicine The Second Hospital of Anhui Medical University Hefei Anhui China.
Qi LiuSchool of Nuclear Science and Technology University of Science and Technology of China Hefei China.
Chenxu ZhouDepartment of Rehabilitation Medicine The Second Hospital of Anhui Medical University Hefei Anhui China.
Guomin WangDepartment of Physics City University of Hong Kong Kowloon, Hong Kong China.
Paul K ChuDepartment of Physics City University of Hong Kong Kowloon, Hong Kong China.
Zhengwei WuSchool of Nuclear Science and Technology University of Science and Technology of China Hefei China.ORCID https://orcid.org/0000-0002-3500-5990
University of Science and Technology of China · CNAnhui Medical University · CNCity University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) has plagued physicians and patients for years due to the lack of targeted treatment. In this study, inspired by the commonality between rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) and cancer cells, the therapeutic effects of cold air plasma (CAP) on RA are studied systematically and thoroughly. In/ex vivo results show that CAP with the proper dosage significantly relieves symptoms including synovial hyperplasia, inflammatory infiltration, and angiogenesis and eliminates the root cause by triggering the self-antioxidant capability of the surrounding tissue. The mechanism on the molecular and cellular level is also revealed that the spontaneous reactive oxygen species (ROS) cascade induces the mitochondrial apoptosis pathway on RA-FLS. This study reveals a new strategy for targeted treatment of RA and the mechanistic study provides the theoretical foundation for future development of plasma medicine.

Indexed as

cold air plasmamitochondrial apoptosis pathwayrheumatoid arthritisROS

Identifiers

PMID36684093
PMCPMC9842019
OpenAlexW4283717501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.